Lacerta Therapeutics


Director, Pre-Clinical Technology

Dr. Shyam Gajavelli brings over two decades of pre-clinical research experience in neurotrauma with viral vectors for gene therapy, cell transplantation, biomarkers, and histological assessments in identifying immunological factors that promote or inhibit neurological repair. He has previously managed state, federal and industry-funded projects—including those from the Department of Defense at the Miami Project to Cure Paralysis at the University of Miami. He brings broad research interests with expertise in animal virology and a particular focus on developing effective gene therapy-based strategies to both mitigate trauma induced cognitive and motor deficits and enhance neural regeneration.